NCT03590821View on ClinicalTrials.gov

Timed Aspirin Chronobiome Study

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2026

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
Healthy
Interventions
DRUG

Aspirin 81 mg

timed administration of aspirin in the evening

DRUG

Celecoxib 200mg capsule

daily administration of celecoxib

Trial Locations (1)

19104

Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT03590821 - Timed Aspirin Chronobiome Study | Biotech Hunter | Biotech Hunter